4Dx Limited is a medical technology company established to commercialize four-dimensional lung imaging technology: 4DxV. 4DxV provides a state-of-the-art, non-invasive way of understanding regional lung motion and airflow in real-time within the breathing lungs. This enables highly detailed maps of patterns of lung motion and pulmonary function, with functional deficits detected through local differences in movement
… Read More
FLUIDDA is active in the field of Functional Respiratory Imaging (FRI) research and development. The company’s proprietary FRI technology offers pharmaceutical companies and healthcare providers a unique entry point into drug development strategies for patients suffering from respiratory diseases such as Idiopathic Pulmonary Fibrosis. Implementation of FRI in the clinical practice creates significant added value to the current healthcare standard in the respiratory field.
Biocellvia performs bespoke digital image analysis for preclinical disease models. Our individual specialised programs are proprietary and customized for each pathology, with internal team of biologists and software developers. The quantitative image analysis is completely automated, precise, and reproducible. The Biocellvia digital method has been fully validated and integrated by biotech and pharmaceutical companies worldwide. Notable collaboration in IPF with Boehringer Ingelheim.
monARC Bionetworks is a healthcare technology company on a mission to modernize the clinical research industry by empowering patients to share their data and participate anytime, anywhere. By allowing patients to directly donate their data, monARC is creating a new data-sharing economy that will transform the highly sequential and siloed drug development model into an integrated and a collaborative model with patients.
Aragen Bioscience is a leading contract research organization, focused on accelerating antibody and other large-molecule pre-clinical development. Our integrated service offerings include: cell line development, protein expression, protein purification, process development, cell-based assays, biophysical assays, and in vivo models of disease. We are based in the San Francisco Bay Area.
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Information on Covance’s solutions can be obtained through its website at covance.com.
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.